ConductScience.org, home

Paper14607828

Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs.

Lai Y and 2 others. J Biol Chem, 2004. Cited by 112 papers, by iCite.

Cite this record

ConductScience Library. Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs. Papers, record 14607828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14607828

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs.
PubMed
Journal
J Biol Chem
PubMed
Year
2004
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
112
iCite
Relative citation ratio, by iCite
2.6
iCite
Revised in PubMed
2021-02-06
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lai YYurong
2Tse CMChung-Ming
3Unadkat JDJashvant D

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
ArabinofuranosyluracilMajor topic
Equilibrative Nucleoside Transporter 1Major topic
Mitochondria, LiverMajor topic
Animals
Biological Transport, Active
Cell Line
Dogs
Humans
In Vitro Techniques
Intracellular Membranes
Membrane Transport Proteins
Recombinant Fusion Proteins
Subcellular Fractions

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
GM54447NIGMS NIH HHSUnited StatesR01GM054447PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.

PMIDTitleJournalYearIn PapersSource
41652173SLC6A6 imports taurine into mitochondria to sustain mitochondrial translation and tumour growth.Nat Metab2026https://conductscience.org/library/papers/41652173PubMed
40958018Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes.Arch Toxicol2025https://conductscience.org/library/papers/40958018PubMed
40900667ToxPoint: The case for Equilibrative Nucleoside Transporters in current regulatory guidance.Toxicol Sci2025https://conductscience.org/library/papers/40900667PubMed
40824221High tide or low tide: the transport and metabolism of mitochondrial nucleotides.Biochem J2025https://conductscience.org/library/papers/40824221PubMed
40083698Mitochondrial Localization and Function of Adenosine Receptors.Int J Biol Sci2025https://conductscience.org/library/papers/40083698PubMed
39983672Solute carriers: The gatekeepers of metabolism.Cell2025https://conductscience.org/library/papers/39983672PubMed
38223529A mechanistic biomarker investigation of fialuridine hepatotoxicity using the chimeric TK-NOG Hu-liver mouse model and in vitro micropatterned hepatocyte cocultures.Toxicol Res (Camb)2024https://conductscience.org/library/papers/38223529PubMed
37404197Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development.Clin Pharmacol Ther2023https://conductscience.org/library/papers/37404197PubMed
36864321Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids.Cell Regen2023https://conductscience.org/library/papers/36864321PubMed
36052127Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment.Front Pharmacol2022https://conductscience.org/library/papers/36052127PubMed
35656081Antiproliferative and apoptotic activity of gemcitabine-lauric acid conjugate on human bladder cancer cells.Iran J Basic Med Sci2022https://conductscience.org/library/papers/35656081PubMed
35257288Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery.Pharm Res2022https://conductscience.org/library/papers/35257288PubMed
35047893Current Perspective: 3D Spheroid Models Utilizing Human-Based Cells for Investigating Metabolism-Dependent Drug-Induced Liver Injury.Front Med Technol2020https://conductscience.org/library/papers/35047893PubMed
34635103Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases.J Biomed Sci2021https://conductscience.org/library/papers/34635103PubMed
34208592Therapy Prospects for Mitochondrial DNA Maintenance Disorders.Int J Mol Sci2021https://conductscience.org/library/papers/34208592PubMed
33690842The equilibrative nucleoside transporter ENT1 is critical for nucleotide homeostasis and optimal erythropoiesis.Blood2021https://conductscience.org/library/papers/33690842PubMed
32730777The utility of a differentiated preclinical liver model, HepaRG cells, in investigating delayed toxicity via inhibition of mitochondrial-replication induced by fialuridine.Toxicol Appl Pharmacol2020https://conductscience.org/library/papers/32730777PubMed
31748707Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models.Nat Rev Drug Discov2020https://conductscience.org/library/papers/31748707PubMed
31600844Identification of a novel heterozygous guanosine monophosphate reductase (GMPR) variant in a patient with a late-onset disorder of mitochondrial DNA maintenance.Clin Genet2020https://conductscience.org/library/papers/31600844PubMed
30059145Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches.Clin Pharmacol Ther2018https://conductscience.org/library/papers/30059145PubMed

See all 45 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
SLC28A19154PubTator's text mininghttps://conductscience.org/library/genes/9154NCBI Gene
SLC29A12030PubTator's text mininghttps://conductscience.org/library/genes/2030NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14607828

GET https://conductscience.org/api/papers/v1/14607828/cited_by?page=2